Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-16-101849

CEO and President acquired 125,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Butler John P. CEO and President 2016-02-22 Grant or award +125,500 351,173 D
Derivatives
Butler John P. CEO and President 2016-02-22 Grant or award · Stock Option (Right to Buy) −190,550 190,550 D
Loading xslF345X03/doc4.xml…